Triple agonist research peptide (GLP-1 / GIP / GCGR)
| Content | 5 mg |
|---|---|
| Vial | 3 ml |
| Purity | ≥99% |
| Storage | Lyophilised powder, stable in transit. On arrival: refrigerated at 2–8°C, away from direct sunlight. |
| Intended use | Laboratory research only |
| Reference | PQ-RET-05 |
Retatrutide is a synthetic peptide studied as a triple agonist of the GLP-1, GIP and glucagon receptors. It belongs to the class of incretin-based research peptides.
It is investigated in metabolic and endocrine research programmes, where it serves as a reference compound for receptor signalling studies. PEPTIQUE supplies Retatrutide in 3 ml vials at four amounts to cover different experimental designs.
A technical comparison of the three incretin peptides studied in metabolic research — mechanism, target receptors, structure, published data, stability, and reconstitution. A laboratory guide.
Read the article →
Guide to interpreting a research peptide's Certificate of Analysis (COA): HPLC chromatography, mass spectrometry, peptide content, water, counterions, endotoxins, batch number, and what a certificate does not say.
Read the article →
Lyophilised powder vs. ready-to-use solution (pen): why form matters. How peptides degrade (hydrolysis, oxidation, deamidation, aggregation), why lyophilisation stabilises them and makes them resistant in transit, what 2–8°C means in practice after receipt, how to store them after reconstitution, and how to check a vial on arrival.
Read the article →
Research use only
Research use only
Research use only
Research use only